ストックスクリーナーアプリを入手
2.58
0.00%
0.00
アフターアワーズ：
2.58
前日終値:
$2.58
開ける：
$2.53
24時間の取引高:
15,095
Relative Volume:
0.17
時価総額：
$7.61M
収益：
$4.88M
当期純損益:
$-3.66M
株価収益率:
-1.6813
EPS:
-1.5345
ネットキャッシュフロー:
$-2.80M
1週間 パフォーマンス:
+10.26%
1か月 パフォーマンス:
+2.38%
6か月 パフォーマンス:
-22.29%
1年 パフォーマンス:
+8.88%
1日の値動き範囲:
$2.5001
$2.61
1週間の範囲:
$2.30
$2.6665
52週間の値動き範囲:
$2.08
$10.16
Biomerica Inc Stock (BMRA) Company Profile
BMRA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
BMRA
Biomerica Inc
|
2.58 | 7.61M | 4.88M | -3.66M | -2.80M | -1.5345 |
|
ABT
Abbott Laboratories
|
125.46 | 214.37B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
92.58 | 136.01B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
354.09 | 134.98B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
99.87 | 127.88B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
83.08 | 48.88B | 5.88B | 1.34B | 799.60M | 2.3489 |
Biomerica Inc Stock (BMRA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2020-11-10 | 開始されました | Colliers Securities | Buy |
| 2018-01-04 | 開始されました | B. Riley FBR, Inc. | Buy |
Biomerica Inc (BMRA) 最新ニュース
Biomerica (BMRA) Gains Approval for Rapid Tests in Egypt - GuruFocus
Egyptian drug authority approves Biomerica’s cancer screening portfolio - Investing.com
Egyptian drug authority approves Biomerica’s cancer screening portfolio By Investing.com - Investing.com Canada
Biomerica, Inc. Receives Authorization from Egyptian Drug Authority for Comprehensive Cancer and Chronic Disease Screening Portfolio - Quiver Quantitative
Biomerica (NASDAQ:BMRA) versus ProKidney (NASDAQ:PROK) Critical Review - Defense World
Retail Trends: Why Biomerica Inc stock is recommended by analystsRisk Management & Target Return Focused Stock Picks - BỘ NỘI VỤ
Why Biomerica Inc. stock is recommended by analystsJuly 2025 Drop Watch & Free Expert Verified Stock Movement Alerts - Newser
Is Biomerica Inc. stock a good choice for value investorsJuly 2025 Big Picture & AI Enhanced Trading Alerts - Newser
Biomerica (BMRA) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Biomerica Expands Contract Manufacturing Services - Orange County Business Journal
Is Biomerica Inc. stock a safe haven asset2025 Trading Volume Trends & Safe Capital Investment Plans - moha.gov.vn
Biomerica's inFoods IBS Product Featured in Biotherapeutics Quarterly - MarketScreener
Biomerica (BMRA) Showcases Innovative IBS Therapy in Biotherapeu - GuruFocus
Biomerica, Inc. Announces Positive Results from Multicenter Clinical Trial on inFoods® IBS Dietary Therapy - Quiver Quantitative
Biomerica Inc. (BMRA) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Why Biomerica Inc. stock appeals to analystsMarket Performance Recap & Breakout Confirmation Alerts - newser.com
Is Biomerica Inc. stock vulnerable to regulatory risksAnalyst Upgrade & Low Drawdown Trading Strategies - newser.com
What momentum shifts mean for Biomerica Inc.Portfolio Value Report & Safe Entry Momentum Tips - newser.com
Is Biomerica Inc. stock ready for a breakoutQuarterly Trade Review & Free Accurate Trade Setup Notifications - newser.com
Biomerica Inc. stock trendline breakdown2025 Stock Rankings & Weekly High Return Stock Opportunities - newser.com
Can machine learning forecast Biomerica Inc. recovery2025 Stock Rankings & Expert Curated Trade Ideas - newser.com
Is it too late to sell Biomerica Inc.Earnings Miss & Technical Entry and Exit Alerts - newser.com
Will Biomerica Inc. stock remain a Wall Street favoriteIndex Update & Fast Momentum Entry Tips - newser.com
What analysts say about Biomerica Inc stockDividend Stock Watch & Small Investment Big Gains - earlytimes.in
How Biomerica Inc. stock compares to market leaders2025 Market Outlook & Low Risk High Win Rate Picks - Fundação Cultural do Pará
How Biomerica Inc. stock reacts to Fed rate cutsEarnings Summary Report & Safe Capital Growth Stock Tips - newser.com
Will Biomerica Inc. stock maintain growth story2025 Pullback Review & Advanced Technical Analysis Signals - newser.com
Biomerica Inc (BMRA) 財務データ
収益
当期純利益
現金流量
EPS
0.52%
0.28%
大文字化:
|
ボリューム (24 時間):